NCT03625557

Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records

Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records (GRECO)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 30 (actual)
• Sponsor: Guardant Health, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To document the clinical outcomes of cancer patients who received the Guardant360® test and agree to share their records with Guardant Health.

Detailed description

This is an observational study of clinical outcomes to be conducted in the United States. Patients with a diagnosis of Stage 3-4 advanced cancer who possess specific pathway mutations identified by the Guardant360® test will be eligible to enroll in the study. Patients will be recruited by telephone or email and/or through the Guardant Health Patient Portal to determine interest in the study. Should patients be interested in contributing to this registry study, they will be prompted to consent via a commercial service for patients to request, manage, and view their medical records. Enrolled participants will be requested to release copies of their medical records for review by the principal investigator. Study adminsitrators will abstract participant demographics, cancer-related therapies, and clinical outcomes for analysis.

Conditions

• Non-Hematologic Malignancy

Timeline

• Start date: 2019-04-30
• Primary completion: 2020-02-01
• Completion: 2020-04-16
• First posted: 2018-08-10
• Last updated: 2020-04-17

Locations

1 site across 1 country: United States